Literature DB >> 11920853

Novel polymorphisms in the promoter region of the neurotrophin-3 gene and their associations with schizophrenia.

Mineko Hattori1, Hiroshi Kunugi, Akihisa Akahane, Hiroshi Tanaka, Sugiko Ishida, Tetsuya Hirose, Ryoji Morita, Kazuhiro Yamakawa, Shinichiro Nanko.   

Abstract

Based on the neurodevelopmental hypothesis in the etiology of schizophrenia, neurotrophic factors may be involved in the pathogenesis of the illness. We searched for polymorphisms in the promoter region of the neurotrophin-3 (NTF3) gene by using denaturing high performance liquid chromatography (DHPLC). Six single nucleotide polymorphisms (SNPs) were found. When these polymorphisms were examined for association with schizophrenia, a weakly significant difference was observed in the genotype distribution of the G/- 3004/A polymorphism between 184 schizophrenics and 185 controls (P < 0.05), although no statistically significant association was detected in a family-based sample of 50 trios (schizophrenics and their parents). With respect to the other polymorphisms, there was no significant association with schizophrenia. The G/- 3004/A polymorphism was in linkage disequilibrium with the CA repeat polymorphism in the first intron of the NTF3 gene. When haplotype-based analysis was performed, an increased frequency of the haplotype containing the G(- 3004) and the "A3" ([CA]23) alleles was observed for the schizophrenics compared to controls. Our results suggest that the G(- 3004)-A3 haplotype has a modest effect of giving susceptibility to schizophrenia. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920853     DOI: 10.1002/ajmg.10248

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  Positive association between NTNG1 and schizophrenia in Chinese Han population.

Authors:  Yuzhang Zhu; Huan Yang; Yuxia Bi; Ying Zhang; Chao Zhen; Shoufu Xie; Heping Qin; Jia He; Li Liu; Ying Liu
Journal:  J Genet       Date:  2011-12       Impact factor: 1.166

Review 2.  Imaging genomics and response to treatment with antipsychotics in schizophrenia.

Authors:  Giuseppe Blasi; Alessandro Bertolino
Journal:  NeuroRx       Date:  2006-01

3.  Possible association between nonsynonymous polymorphisms of the anaplastic lymphoma kinase (ALK) gene and schizophrenia in a Japanese population.

Authors:  H Kunugi; R Hashimoto; T Okada; H Hori; T Nakabayashi; A Baba; K Kudo; M Omori; S Takahashi; R Tsukue; K Anami; N Hirabayashi; A Kosuga; M Tatsumi; K Kamijima; T Asada; S Harada; K Arima; O Saitoh
Journal:  J Neural Transm (Vienna)       Date:  2006-04-11       Impact factor: 3.575

4.  Dysregulation of the fibroblast growth factor system in major depression.

Authors:  S J Evans; P V Choudary; C R Neal; J Z Li; M P Vawter; H Tomita; J F Lopez; R C Thompson; F Meng; J D Stead; D M Walsh; R M Myers; W E Bunney; S J Watson; E G Jones; H Akil
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-13       Impact factor: 11.205

Review 5.  [Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness].

Authors:  A Schuld; D Hinze-Selch; Th Pollmächer
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

Review 6.  Genomic studies of mood disorders -- the brain as a muscle?

Authors:  Alexander B Niculescu
Journal:  Genome Biol       Date:  2005-03-24       Impact factor: 13.583

Review 7.  The genes for schizophrenia: finally a breakthrough?

Authors:  Brian H Shirts; Vishwajit Nimgaonkar
Journal:  Curr Psychiatry Rep       Date:  2004-08       Impact factor: 8.081

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.